To: Lanzhou Foci Pharmaceutical Co., Ltd.
GanSu JinCheng Law Firm (hereinafter referred to as "the Firm") has been engaged by Lanzhou Foci Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") to provide legal opinions regarding the second extraordinary shareholders' meeting of the Company scheduled for 2026 (hereinafter referred to as "the Meeting"). Based on the relevant laws and regulations, including the Company Law of the People's Republic of China, we hereby present our legal opinion as follows: